Form 8-K - Current report:
SEC Accession No. 0001193125-21-044801
Filing Date
2021-02-16
Accepted
2021-02-16 16:01:14
Documents
23
Period of Report
2021-02-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d137638d8k.htm   iXBRL 8-K 42878
2 EX-1.1 d137638dex11.htm EX-1.1 182533
3 EX-5.1 d137638dex51.htm EX-5.1 7547
4 EX-10.1 d137638dex101.htm EX-10.1 63073
5 EX-10.2 d137638dex102.htm EX-10.2 86540
6 EX-99.1 d137638dex991.htm EX-99.1 8183
7 EX-99.2 d137638dex992.htm EX-99.2 9018
11 GRAPHIC g137638g0212105201206.jpg GRAPHIC 2744
12 GRAPHIC g137638g0212105733134.jpg GRAPHIC 3538
13 GRAPHIC g137638g0212105733259.jpg GRAPHIC 1853
14 GRAPHIC g137638g0212110243001.jpg GRAPHIC 3538
15 GRAPHIC g137638g0212110243125.jpg GRAPHIC 1853
  Complete submission text file 0001193125-21-044801.txt   656472

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA acet-20210210.xsd EX-101.SCH 3073
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acet-20210210_lab.xml EX-101.LAB 18888
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acet-20210210_pre.xml EX-101.PRE 11862
16 EXTRACTED XBRL INSTANCE DOCUMENT d137638d8k_htm.xml XML 3468
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 21637745
SIC: 2834 Pharmaceutical Preparations